COVID-19流行高峰期临床用血特点分析及对策

Analysis on the characteristics and Countermeasures of Clinical Blood use in the Peak period of COVID-19 epidemic

目的了解COVID-19流行期间重庆市某三甲医院临床用血特点,为突发公共卫生事件期间临床用血保障提供依据。方法采用回顾性统计分析,比较2019年2月与2020年2月我院各成分血临床用量差异。结果2020年2月,本院临床用血量为2415 U,明显低于2019年同期的6092 U,各成分血中,红细胞制剂临床用量下降最为明显,同比降低34%,其次为血小板制剂;在血型差异上,2019年2月各成分血以O型为主,而2020年同期以B型为主;2020年2月疫情期间,本院住院患者以消化科用血占比最高,与2019年同期有显著差异。结论突发公共卫生期间临床用血特点异于常规,在特殊情况下应尽早建立应急措施,为临床用血提供有力保障。

Objective To understand the characteristics of clinical blood use in a third-class hospital in Chongqing during the epidemic of COVID-19,and to provide basis for ensuring clinical blood use during public health emergencies.Methods Retrospective statistical analysis was used to compare the difference of clinical dosage of blood components in our hospital between February 2020 and February 2019.Results In February 2020,the clinical blood consumption of the hospital was 2415 U,which was significantly lower than that of 6092 U in the same period in 2019.Among all components of blood,the clinical dosage of red blood cell preparation decreased most significantly,with a year-on-year decrease of 34%,followed by platelet preparation.In terms of blood type differences,type O was the main component of blood in February 2019,while type B was dominant in the same period in 2020.During the epidemic in February 2020,the proportion of blood consumption in digestive department was the highest in our hospital,which was significantly different from that in the same period in 2019.Conclusions The characteristics of clinical blood use during the period of sudden public health are different from the routine time.Under special circumstances,emergency measures should be established as soon as possible to provide a strong guarantee for clinical blood use.